Molecular genetics of age-related macular degeneration: Current status

European Journal of Ophthalmology

Volumn 9, Issue 4, 1999, Pages 255-265

  Allikmets, Rando ^a,b  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

ABCR; Age related macular degeneration; Association; Candidate genes; Complex trait; Genetic predisposition

Indexed keywords

AGE; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; MOLECULAR GENETICS; PREVALENCE; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA MACULA DEGENERATION; REVIEW; VISUAL IMPAIRMENT;

EID: 0033399473     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067219900900401     Document Type: Review

References (69)

1. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 1994; 272: 1413-20.
2. Seddon JM, Willett WC, Speizer FE, et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996; 276: 1141-6.
3. Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114: 1518-23.
4. Mitchell P, Smith W, Wang JJ. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. Ophthalmology 1998; 105: 1359-63.
5. VandenLangenberg GM, Mares-Perlman JA, Klein R, et al. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 1998; 148: 204-14.
6. Mares-Perlman JA, Brady WE, Klein R, et al. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995; 113: 743-8.
7. Hirvela H, Luukinen H, Laara E, et al. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 1996; 103: 871-7.
8. Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol 1994; 112: 932-7.
9. Heiba IM, Elston RC, Klein BE, et al. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 1994; 11: 51-67.
10. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997; 123: 199-206.
11. Silvestri G, Johnston PB, Hughes AE. Is genetic predisposition an important risk factor in age-related macular degeneration? Eye 1994; 8: 564-8.
12. Klaver CC, Wolfs RC, Assink JJ, et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998; 116: 1646-51.
13. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933-43.
14. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995; 102: 205-10.
15. Rosenberg T, Klie F. The incidence of registered blindness caused by age-related macular degeneration. Acta Ophthalmol Scand 1996; 74: 399-402.
16. Evans J, Wormald R. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 1996; 80: 9-14.
17. Cruickshanks KJ, Hamman RF, Klein R, et al. The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy. Arch Ophthalmol 1997; 115: 242-50.
18. Klein R, Klein BE, Jensen SC, et al. Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 1999; 106: 1056-65.
19. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988; 32: 375-413.
20. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-74.
21. Sunness JS, Gonzalez-Baron J, Bressler NM, et al. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 1999; 106: 910-9.
22. Seddon JM, Samelson LJ, Page WF, et al. Twin study of macular degeneration: methodology and application to genetic epidemiologic studies. Invest Ophthalmol Vis Sci 1997; 38 (suppl): S676.
23. Curcio CA, Medeiros NE, Millican CL. The Alabama Age-Related Macular Degeneration Grading System for donor eyes. Invest Ophthalmol Vis Sci 1998; 39: 1085-96.
24. The Age-Related Eye Disease Study (AREDS): Design Implications. Control Clin Trials 1999; (in press).
25. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98: 1128-34.
26. O'Donovan MC, Owen MJ. Candidate-gene association studies of schizophrenia. Am J Hum Genet 1999; 65: 587-92.
27. Klein ML, Schultz DW, Edwards A, et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch Ophthalmol 1998; 116: 1082-8.
28. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-7.
29. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-16.
30. Weber BH, Vogt G, Pruett RC, et al. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994; 8: 352-6.
31. Andreu T, Beckers T, Thoenes E, et al. Gene trapping identifies inhibitors of oncogenic transformation. The tissue inhibitor of metalloproteinases-3 (TIMP3) and collagen type 1 alpha2 (COL1α2) are epidermal growth factor-regulated growth repressers. J Biol Chem 1998; 273: 13848-54.
32. Felbor U, Doepner D, Schneider U, et al. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies. Invest Ophthalmol Vis Sci 1997; 38: 1054-9.
33. De La Paz MA, Pericak-Vance MA, Lennon F, et al. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. Invest Ophthalmol Vis Sci 1997; 38: 1060-5.
34. Petrukhin K, Koisti MJ, Bakall B, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet 1998; 19: 241-7.
35. Marquardt A, Stohr H, Passmore LA, et al. Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). Hum Mol Genet 1998; 7: 1517-25.
36. Allikmets R, Seddon JM, Bernstein PS, et al. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet 1999; 104: 449-53.
37. Stone EM, Lotery AJ, Munier FL, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 1999; 22: 199-202.
38. Ikegawa S, Toda T, Okui K, et al. Structure and chromosomal assignment of the human S1-5 gene (FBNL) that is highly homologous to fibrillin. Genomics 1996; 35: 590-2.
39. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy (see comments). Nat Genet 1997; 15: 236-46.
40. Martinez-Mir A, Paloma E, Allikmets R, et al. Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR (letter; comment). Nat Genet 1998; 18: 11-2.
41. Cremers FP, van de Pol DJ, van Driel M, et al. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. Hum Mol Genet 1998; 7: 355-62.
42. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277: 1805-7.
43. Stone EM, Webster AR, Vandenburgh K, et al. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet 1998; 20: 328-9.
44. Kuroiwa S, Kojima H, Kikuchi T, et al. ATP binding cassette transporter retina genotypes and age related macular degeneration: an analysis on exudative non-familial Japanese patients. Br J Ophthalmol 1999; 83: 613-5.
45. De La Paz MA, Guy VK, Abou-Donia S, et al. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology 1999; 106: 1531-6.
46. Lewis RA, Shroyer NF, Singh N, et al. Genotype/Phenotype analysis of a photoreceptor-specific ATP-binding cassette transporter gene, ABCR, in Stargardt disease. Am J Hum Genet 1999; 64: 422-34.
47. Maugeri A, van Driel MA, van de Pol DJ, et al. The 2588G->C mutation in the ABCR gene is a mild frequent founder mutation in the western european population and allows the classification of ABCR mutations in patients with Stargardt disease. Am J Hum Genet 1999; 64: 1024-35.
48. Fishman GA, Stone EM, Grover S, et al. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol 1999; 117: 504-10.
49. Long AD, Langley CH. The power of association studies to detect the contribution of candidate genetic loci to variation in complex traits. Genome Res 1999; 9: 720-31.
50. Allikmets R, Hutchinson A, Lewis RA, et al. Association of G1961E and D2177N variants in the ABCR gene with age-related macular degeneration (ARVO Abstract). Invest Ophthalmol Vis Sci 1999; 40 (suppl): S775.
51. van Driel MA, Maugeri A, Klevering BJ, et al. ABCR unites what ophthalmologists divide(s). Ophthalmic Genet 1998; 19: 117-22.
52. Shroyer NF, Lewis RA, Allikmets R, et al. The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res 1999; 39: 2537-44.
53. Simonelli F, Testa F, de Crecchio G, et al. New ABCR mutations and clinical phenotype in Italian patients with Stargardt disease. Invest Ophthalmol Vis Sci 1999 (in press).
54. Souied EH, Ducroq D, Gerber S, et al. Age-related macular degeneration in grandparents of patients with Stargardt disease: genetic study. Am J Ophthalmol 1999; 128: 173-8.
55. Sun H, Nathans J. Stargardt s ABCR is localized to the disc membrane of retinal rod outer segments. Nat Genet 1997; 17: 15-6.
56. Sun H, Molday RS, Nathans J. Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. J Biol Chem 1999; 274: 8269-81.
57. Weng J, Mata NL, Azarian SM, et al. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 1999; 98: 13-23.
58. Zhang K, Kniazeva M, Hutchinson A, et al. The ABCR gene in recessive and dominant Stargardt diseases: A genetic pathway in macular degeneration. Genomics 1999; 60: 234-7.
59. Marlhens F, Bareil C, Griffoin JM, et al. Mutations in RPE65 cause Leber's congenital amaurosis. Nat Genet 1997; 17: 139-41.
60. Gu SM, Thompson DA, Srikumari CR, et al. Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet 1997; 17: 194-7.
61. Kniazeva M, Chiang MF, Morgan B, et al. A new locus for autosomal dominant stargardt-like disease maps to chromosome 4. Am J Hum Genet 1999; 64: 1394-9.
62. Nichols BE, Sheffield VC, Vandenburgh K, et al. Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene. Nat Genet 1993; 3: 202-7.
63. Wells J, Wroblewski J, Keen J, et al. Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet 1993; 3: 213-8.
64. Felbor U, Schilling H, Weber BH. Adult vitelliform macular dystrophy is frequently associated with mutations in the peripherin/RDS gene. Hum Mutat 1997; 10: 301-9.
65. Stone EM, Nichols BE, Kimura AE, et al. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch Ophthalmol 1994; 112: 765-72.
66. Kelsell RE, Gregory-Evans K, Gregory-Evans CY, et al. Localization of a gene (CORD7) for a dominant cone-rod dystrophy to chromosome 6q. Am J Hum Genet 1998; 63: 274-9.
67. Small KW, Weber J, Roses A, et al. North Carolina macular dystrophy (MCDR1). A review and refined mapping to 6q14-q16.2. Ophthalmic Paediatr Genet 1993; 14: 143-50.
68. Kelsell RE, Godley BF, Evans K, et al. Localization of the gene for progressive bifocal chorioretinal atrophy (PBCRA) to chromosome 6q. Hum Mol Genet 1995; 4: 1653-6.
69. Small KW, Syrquin M, Mullen L, et al. Mapping of autosomal dominant cone degeneration to chromosome 17p. Am J Ophthalmol 1996; 121: 13-8.